Bear of the Day: PetMed Express (PETS)

PetMed Express (PETS) reported another disappointing quarter with EPS of $0.20, in line with the Zacks Consensus Estimate although lower than the year-ago quarter’s $0.25. Revenues continued to slide with a decline in new order sales and fewer new customers.

Moreover, both gross and operating margins declined driven by higher product and advertising costs. This is a big blow for the company, as it depends on advertising to increase its customer base. Moreover, economic uncertainty is taking a toll on the company, forcing consumers to switch to cheaper alternatives.

We do no expect the situation to improve significantly in the near future. We have lowered our estimates for 2012 and reiterate Underperform recommendation.

PETMED EXPRESS (PETS): Free Stock Analysis Report

About Zacks Investment Research 1766 Articles

Zacks Investment Research is one of the most highly regarded firms in the investment industry. In 1978 Zacks originated the concept of utilizing earnings estimates revisions to make profitable investment decisions. Zacks offers multiple investment products and services to help investors achieve superior returns.


Be the first to comment

Leave a Reply

Your email address will not be published.